Novel therapies for diffuse intrinsic pontine glioma (DIPG)

Associate Professor David Ziegler from the Children's Cancer Institute is researching therapies for diffuse intrinsic pontine glioma (DIPG).
Associate Professor David Ziegler from the Children's Cancer Institute is researching therapies for diffuse intrinsic pontine glioma (DIPG).

Recipient: Associate Professor David Ziegler
Institute: Children’s Cancer Institute
Funding: $583,142 July 2016 to June 2019

Medical research is the only way to help children with this disease. 

Diffuse intrinsic pontine glioma (DIPG) is a devastating childhood cancer. With very few treatment options and no cure, the only way to help children with this disease is through medical research.

This project headed by Associate Professor Ziegler, focuses on the development of a new drug that can target DIPG cells specifically, causing them to die. Ultimately, this novel project aims to gather the necessary pre-clinical data required to progress to human trials.